Centivax: Valuation, Funding & Investors
Centivax is a biotechnology company focused on engineering vaccines and therapies designed to provide durable, universal protection against a wide range of highly diverse targets.
Leadership & Board
- Current Number of Employees
- 36
- Current LinkedIn Followers
- 5,796
Latest Estimated Valuation
- Total Amount Raised
- $82M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $37M
- Latest Funding Round
- Investment
Employee Trend
Centivax had 36 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
36Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Centivax had 5,796 followers as of November 9, 2026. The number of followers increased by 4 (0.07%) week-over-week.
5,796Latest Followers Count
4(0.07%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Mar 30, 2026 | Investment | $37.00M | ― |
| Jul 08, 2025 | Series A | $45.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Structure Fund | Investment |
| Sigmas Group | Investment |
| Kendall Capital Partners | Investment |
| Patrick Collison | Investment |
| John Collison | Investment |
| BOLD Capital Partners | Series A |
| Future Ventures | Series A |
| NFX | Series A |
Similar Companies
A snapshot of private companies similar to Centivax, helping you discover and navigate related company profiles.
Related News and Analysis
